These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28458158)

  • 1. HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer.
    Sun L; Lü J; Ding S; Bi D; Ding K; Niu Z; Liu P
    Biomed Pharmacother; 2017 Jul; 91():202-207. PubMed ID: 28458158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation.
    Yang W; Wang JG; Wang Q; Qin Y; Lin X; Zhou D; Ren K; Hou C; Xu J; Liu X
    Biochem Biophys Res Commun; 2016 Aug; 477(2):222-8. PubMed ID: 27311861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.
    Xu H; Miao ZF; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Zhang JY; Liu XY; Wu JH; Xu HM
    Virchows Arch; 2017 Dec; 471(6):743-751. PubMed ID: 28963677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Wu Y; Yang Y; Xian YS
    Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
    Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
    Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of HCRP1 inhibits proliferation and invasion in glioma cells via suppressing the ERK and AKT signaling pathways.
    Xu CY; Li ZJ; Hu WZ
    Biomed Pharmacother; 2017 Nov; 95():31-36. PubMed ID: 28826094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCRP1 is downregulated in non-small cell lung cancer and regulates proliferation, invasion, and drug resistance.
    Du Y; Wang P; Sun H; Yang J; Lang X; Wang Z; Zang S; Chen L; Ma J; Sun D
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27739029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.
    Tomasich E; Topakian T; Heller G; Udovica S; Krainer M; Marhold M
    Transl Res; 2021 Apr; 230():21-33. PubMed ID: 33197651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling mechanisms that mediate invasion in prostate cancer cells.
    Bonaccorsi L; Marchiani S; Muratori M; Carloni V; Forti G; Baldi E
    Ann N Y Acad Sci; 2004 Dec; 1028():283-8. PubMed ID: 15650253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells.
    Festuccia C; Gravina GL; Millimaggi D; Muzi P; Speca S; Ricevuto E; Vicentini C; Bologna M
    Oncol Rep; 2007 Aug; 18(2):503-11. PubMed ID: 17611677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
    Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells.
    Zhu G; Zhou J; Song W; Wu D; Dang Q; Zhang L; Li L; Wang X; He D
    Oncol Rep; 2013 Aug; 30(2):904-10. PubMed ID: 23757299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma.
    Chen F; Deng J; Liu X; Li W; Zheng J
    Sci Rep; 2015 Aug; 5():13470. PubMed ID: 26304749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
    Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells.
    Kharait S; Dhir R; Lauffenburger D; Wells A
    Biochem Biophys Res Commun; 2006 May; 343(3):848-56. PubMed ID: 16564022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
    Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
    Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.
    Wittinger M; Vanhara P; El-Gazzar A; Savarese-Brenner B; Pils D; Anees M; Grunt TW; Sibilia M; Holcmann M; Horvat R; Schemper M; Zeillinger R; Schöfer C; Dolznig H; Horak P; Krainer M
    Clin Cancer Res; 2011 Dec; 17(24):7816-27. PubMed ID: 22016507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.